JPMorgan Chase & Co’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7
| Closed | -$5 | – | 6773 |
|
|
2023
Q2 | $5 | Hold |
7
| – | – | ﹤0.01% | 5927 |
|
|
2023
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 6269 |
|
|
2022
Q4 | $0 | Sell |
7
-1
| -13% | – | ﹤0.01% | 6125 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 5984 |
|
|
2022
Q2 | $0 | Sell |
8
-5,309
| -100% | – | ﹤0.01% | 6068 |
|
|
2022
Q1 | $64K | Buy |
5,317
+1,022
| +24% | +$12.3K | ﹤0.01% | 4924 |
|
|
2021
Q4 | $84K | Hold |
4,295
| – | – | ﹤0.01% | 4896 |
|
|
2021
Q3 | $111K | Sell |
4,295
-2,682
| -38% | -$69.3K | ﹤0.01% | 4669 |
|
|
2021
Q2 | $154K | Buy |
+6,977
| New | +$154K | ﹤0.01% | 4604 |
|
|
2019
Q2 | – | Sell |
-263
| Closed | -$10K | – | 4991 |
|
|
2019
Q1 | $10K | Hold |
263
| – | – | ﹤0.01% | 4639 |
|
|
2018
Q4 | $12K | Buy |
263
+49
| +23% | +$2.24K | ﹤0.01% | 4589 |
|
|
2018
Q3 | $29K | Sell |
214
-27
| -11% | -$3.66K | ﹤0.01% | 4510 |
|
|
2018
Q2 | $114K | Buy |
+241
| New | +$114K | ﹤0.01% | 4039 |
|